Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12221422
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
granted -
US 12221491
PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
granted -
US 12220453
Compositions and treatments for Haemophilus influenzae
granted -
US 12220389
Combination therapy for the treatment of tinnitus and other medical conditions
granted -
US 12220420
Combination therapy for cancer treatment
granted -
US 12213951
Treatment of autism with cannabidiol
granted -
US 12213989
Use of maribavir in treatment regimens
granted -
US 12214045
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods
granted -
US 12215316
Materials and methods for treatment of usher syndrome type 2A
granted -
US 12215322
Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors
granted -
US 12215349
Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same
granted -
US 2025034260
FCRN ANTAGONISTS FOR TREATMENT OF IGG-RELATED DISEASES AND DISORDERS
granted -
US 12208123
Compositions and methods for the treatment of skin conditions
granted -
US 12209140
Therapeutics for the treatment of glaucoma
granted -
US 12201617
HDAC6 inhibitors for treatment of metabolic disease and HFpEF
granted -
US 12201700
Micro- and nano-device for cartilage injury detection and treatment
granted -
US 12201673
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 12201604
Treatment of circadian rhythm disorders
granted -
US 12201658
Viral gene therapy as treatment for cholesterol storage disease or disorder
granted -
US 12201601
Treatment for obesity
granted -
US 12202880
HLA engineering methods and compositions for treatment of autoimmunity
granted -
US 12194078
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
granted -
US 12194079
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
granted -
US 12194082
Compositions and methods for treatment of homocystinuria
granted